Corrigendum: Targeting Myc Interacting Proteins as a Winding Path in Cancer Therapy

Front Pharmacol. 2021 Oct 20:12:785732. doi: 10.3389/fphar.2021.785732. eCollection 2021.

Authors

Yihui Zhou¹, Xiaomeng Gao¹, Meng Yuan², Bo Yang^{1

2}, Qiaojun He^{1

2

3}, Ji Cao^{1

2

3}

Affiliations

¹ Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
² The Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University, Hangzhou, China.
³ Cancer Center of Zhejiang University, Hangzhou, China.

Abstract

[This corrects the article DOI: 10.3389/fphar.2021.748852.].

Keywords: MYC; cancer therapy; inhibitors; interaction protein; post-translational modification; transcriptional regulation.

Copyright © 2021 Zhou, Gao, Yuan, Yang, He and Cao.

Publication types

Published Erratum